Barzilai University Medical Center

127 Research Day 2020 Barzilai University Medical Center 91 PATIENT WILLINGNESS TO CONTRIBUTE TO THE COST OF NOVEL IMPLANTS IN TOTAL JOINT ARTHROPLASTY: THE CANADIAN EXPERIENCE Fuhrmann A 1 ,2 , Batash R 2 , Schwarzkopf R 3 , Backstein D 1 . 1 Division of Orthopedics, Mount Sinai Hospital, Toronto, Ont. 2 Department of Orthopedics, Barzilai University Medical Centre, Ashkelon, Israel 3 Department of Orthopedic Surgery, NYU Langone Medical Center, New York, N.Y. Background In Canada, health care is covered by provincial health insurance programs; patients do not directly participate in paying for their acute care expenses. The aim of this study is to assess the willingness of Canadian patients to contribute to the costs of novel total joint arthroplasty implants. Hypothesis Patients will be willing to copay to have access to new technologies and novel implants. Objectives We administered a questionnaire to patients attending an outpatient arthroplasty clinic in Ontario. In the questionnaire, the longevity and risk of complications of a “standard” implant were described. We asked if participants would be willing to contribute to the cost of 3 novel implants that had differing longevities and risks of complications compared with the standard implant. Results One hundred and fifteen patients completed our questionnaire. Up to 62% of patients were willing to contribute a copayment to get an implant with greater longevity. Willingness to pay decreased to 40% for an implant with greater longevity but an increased risk of complications. Forty percent of participants were willing to pay for an implant with the same longevity as the standard implant but a decreased risk of complications. Participants with a higher income were more willing than other participants to contribute to the cost of a novel implant with greater longevity or lower complication rates. Conclusions This study demonstrated that up to 62% of our sample of patients in Ontario were willing to share the costs of a novel total joint replacement implant. Willingness to pay was associated with the proposed benefits of the implant and certain patient characteristics. Our study shows that a high proportion of Canadian patients may be willing to copay to have access to new technologies.